Management of Adrenal Insufficiency Following Abrupt Steroid Discontinuation
Patients who abruptly discontinue long-term steroid therapy should be immediately evaluated for adrenal insufficiency and referred to an endocrinologist for proper management, as sudden steroid withdrawal can lead to life-threatening adrenal crisis. 1
Clinical Manifestations of Adrenal Insufficiency
Abrupt discontinuation of long-term systemic steroids leads to adrenal insufficiency due to hypothalamic-pituitary-adrenal (HPA) axis suppression. Early recognition of symptoms is critical as volume-resistant hypotension may be a late or even agonal event 2.
Signs and symptoms include:
- Non-specific malaise
- Somnolence or altered mental status
- Cognitive dysfunction
- Orthostatic hypotension progressing to supine hypotension and shock
- Hyponatremia
- Hyperkalemia
- Hypoglycemia
- Persistent unexplained fever
- Nausea and vomiting
- Weakness and fatigue
Laboratory Evaluation
The following tests should be performed immediately:
- Electrolytes (sodium, potassium, chloride, bicarbonate)
- Blood glucose
- Morning cortisol level (though this may not be diagnostic in patients on corticosteroids)
- ACTH level (to differentiate between primary and secondary adrenal insufficiency)
- Cortisol stimulation test (if patient is stable enough) 1
Immediate Management
For patients with severe symptoms or suspected adrenal crisis:
- Administer IV hydrocortisone 100 mg every 6-8 hours immediately
- Provide IV normal saline for volume depletion and hyponatremia correction
- Monitor vital signs, including orthostatic blood pressure measurements
- Check electrolytes frequently 1
For patients with less severe symptoms:
- Initiate oral hydrocortisone replacement at 15-20 mg daily in divided doses (10-15 mg in morning, 5 mg in early afternoon)
- Add fludrocortisone 0.05-0.1 mg once daily if primary adrenal insufficiency is suspected 1
Long-term Management and Referral
All patients with adrenal insufficiency following steroid discontinuation should be referred to an endocrinologist for:
- Adjustment of hydrocortisone dose based on clinical response (maximum daily dose of 30 mg)
- Education on stress-dose protocols (doubling or tripling hydrocortisone dose during illness)
- Prescription of emergency injectable hydrocortisone
- Recommendation for medical alert bracelet/necklace
- Testing for HPA axis recovery after 3 months of maintenance therapy 1
Prevention of Adrenal Insufficiency
To prevent adrenal insufficiency when discontinuing steroids:
- Taper steroids gradually, reducing by no more than 2.5-5 mg every 1-2 weeks
- For patients who have been on prolonged therapy, taper even more slowly
- Stress-dose steroids should be tapered over 5-7 days to maintenance doses 1, 3
Special Considerations
- Patients with adrenal insufficiency are at risk during periods of physiological stress and should follow "Sick Day Rules" by doubling steroid doses during illness 2
- Patients should be educated about the symptoms of adrenal insufficiency and when to seek medical attention
- The risk of adrenal insufficiency varies according to dose from 2.4% (low dose) to 21.5% (high dose), and according to treatment duration from 1.4% (<28 days) to 27.4% (>1 year) 4
- Recovery of adrenal function typically occurs within 6-12 months but can take up to 51 months in some cases 5, 6
- Approximately 5% of patients may never recover normal adrenal function 6
Pitfalls to Avoid
- Do not delay treatment in patients with suspected adrenal crisis while waiting for confirmatory testing
- Do not start thyroid hormone replacement before cortisol replacement in patients with multiple hormone deficiencies
- Do not assume patients are fully educated about sick day rules or adrenal crisis management
- Be vigilant for hypercalcemia, which can be a rare presentation of glucocorticoid-induced adrenal insufficiency 7
- Never abruptly discontinue steroids in patients who have been on long-term therapy 3
By following these guidelines, clinicians can effectively manage patients who have developed adrenal insufficiency following abrupt steroid discontinuation and prevent potentially life-threatening complications.